Outlook Therapeutics, Inc.

OTLK·NASDAQ·$0.40Share Price as of 11/2·$16MMarket Cap as of 11/2

Financials

10-QQ3 ended 06/30/2608/18/26 10-QQ2 ended 03/31/2605/15/26 10-QQ1 ended 12/31/2502/17/26 10-KFY 202512/19/25 10-QQ3 ended 06/30/2508/14/25

Disclosures

8-KCurrent report09/30/26 8-KCurrent report09/18/26 8-KCurrent report08/27/26 8-KCurrent report08/14/26 8-KCurrent report08/14/26

Prospectuses and Registrations

424B5Prospectus supplement08/14/26 424B5Prospectus supplement08/12/26 424B3Prospectus07/21/26 S-3Shelf registration07/17/26 424B5Prospectus supplement05/29/26

Proxies

DEFA14AAdditional proxy materials07/10/26 DEF 14ADefinitive proxy06/01/26 DEFA14AAdditional proxy materials06/01/26 PRE 14APreliminary proxy05/22/26 DEF 14ADefinitive proxy01/26/26

Ownership

SC 13GBeneficial ownership10/13/26 Form 3Initial insider ownership09/02/26 Form 4Insider transaction09/02/26 SC 13GBeneficial ownership08/19/26 Form 4Insider transaction08/14/26

Other

NT 10-QLate filing notification (10-Q)08/17/26 EFFECTRequest for effectiveness07/21/26 DRSDRS07/08/26 DD05/07/26 ARSAnnual report to shareholders01/26/26